Global Exosome Rapid Molecular Detection Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Exosome Rapid Molecular Detection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Exosome Rapid Molecular Detection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Kits & Reagents
1.2.3 Instruments
1.2.4 Services
1.3 Market Segmentation by Application
1.3.1 Global Exosome Rapid Molecular Detection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cancers
1.3.3 Neurodegenerative Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Exosome Rapid Molecular Detection Revenue Estimates and Forecasts 2020-2031
2.2 Global Exosome Rapid Molecular Detection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Exosome Rapid Molecular Detection Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Exosome Rapid Molecular Detection Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Kits & Reagents Market Size by Players
3.3.2 Instruments Market Size by Players
3.3.3 Services Market Size by Players
3.4 Global Exosome Rapid Molecular Detection Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Exosome Rapid Molecular Detection Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Exosome Rapid Molecular Detection Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Exosome Rapid Molecular Detection Market Size by Type (2020-2031)
6.4 North America Exosome Rapid Molecular Detection Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Exosome Rapid Molecular Detection Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Exosome Rapid Molecular Detection Market Size by Type (2020-2031)
7.4 Europe Exosome Rapid Molecular Detection Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Exosome Rapid Molecular Detection Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Exosome Rapid Molecular Detection Market Size by Type (2020-2031)
8.4 Asia-Pacific Exosome Rapid Molecular Detection Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Exosome Rapid Molecular Detection Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Exosome Rapid Molecular Detection Market Size by Type (2020-2031)
9.4 Central and South America Exosome Rapid Molecular Detection Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Exosome Rapid Molecular Detection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Exosome Rapid Molecular Detection Market Size by Type (2020-2031)
10.4 Middle East and Africa Exosome Rapid Molecular Detection Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Exosome Rapid Molecular Detection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Exosome Rapid Molecular Detection Product Features and Attributes
11.1.4 Thermo Fisher Scientific Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Exosome Rapid Molecular Detection Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Exosome Rapid Molecular Detection Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Exosome Rapid Molecular Detection Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Exosome Rapid Molecular Detection SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Corporation Information
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Exosome Rapid Molecular Detection Product Features and Attributes
11.2.4 Bio-Techne Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.2.5 Bio-Techne Exosome Rapid Molecular Detection Revenue by Product in 2024
11.2.6 Bio-Techne Exosome Rapid Molecular Detection Revenue by Application in 2024
11.2.7 Bio-Techne Exosome Rapid Molecular Detection Revenue by Geographic Area in 2024
11.2.8 Bio-Techne Exosome Rapid Molecular Detection SWOT Analysis
11.2.9 Bio-Techne Recent Developments
11.3 System Biosciences
11.3.1 System Biosciences Corporation Information
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Exosome Rapid Molecular Detection Product Features and Attributes
11.3.4 System Biosciences Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.3.5 System Biosciences Exosome Rapid Molecular Detection Revenue by Product in 2024
11.3.6 System Biosciences Exosome Rapid Molecular Detection Revenue by Application in 2024
11.3.7 System Biosciences Exosome Rapid Molecular Detection Revenue by Geographic Area in 2024
11.3.8 System Biosciences Exosome Rapid Molecular Detection SWOT Analysis
11.3.9 System Biosciences Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Corporation Information
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Exosome Rapid Molecular Detection Product Features and Attributes
11.4.4 QIAGEN Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.4.5 QIAGEN Exosome Rapid Molecular Detection Revenue by Product in 2024
11.4.6 QIAGEN Exosome Rapid Molecular Detection Revenue by Application in 2024
11.4.7 QIAGEN Exosome Rapid Molecular Detection Revenue by Geographic Area in 2024
11.4.8 QIAGEN Exosome Rapid Molecular Detection SWOT Analysis
11.4.9 QIAGEN Recent Developments
11.5 Lonza
11.5.1 Lonza Corporation Information
11.5.2 Lonza Business Overview
11.5.3 Lonza Exosome Rapid Molecular Detection Product Features and Attributes
11.5.4 Lonza Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.5.5 Lonza Exosome Rapid Molecular Detection Revenue by Product in 2024
11.5.6 Lonza Exosome Rapid Molecular Detection Revenue by Application in 2024
11.5.7 Lonza Exosome Rapid Molecular Detection Revenue by Geographic Area in 2024
11.5.8 Lonza Exosome Rapid Molecular Detection SWOT Analysis
11.5.9 Lonza Recent Developments
11.6 NX Pharmagen
11.6.1 NX Pharmagen Corporation Information
11.6.2 NX Pharmagen Business Overview
11.6.3 NX Pharmagen Exosome Rapid Molecular Detection Product Features and Attributes
11.6.4 NX Pharmagen Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.6.5 NX Pharmagen Recent Developments
11.7 NanoSomiX
11.7.1 NanoSomiX Corporation Information
11.7.2 NanoSomiX Business Overview
11.7.3 NanoSomiX Exosome Rapid Molecular Detection Product Features and Attributes
11.7.4 NanoSomiX Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.7.5 NanoSomiX Recent Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Corporation Information
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Exosome Rapid Molecular Detection Product Features and Attributes
11.8.4 Miltenyi Biotech Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.8.5 Miltenyi Biotech Recent Developments
11.9 Norgen Biotek
11.9.1 Norgen Biotek Corporation Information
11.9.2 Norgen Biotek Business Overview
11.9.3 Norgen Biotek Exosome Rapid Molecular Detection Product Features and Attributes
11.9.4 Norgen Biotek Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.9.5 Norgen Biotek Recent Developments
11.10 AMSBio
11.10.1 AMSBio Corporation Information
11.10.2 AMSBio Business Overview
11.10.3 AMSBio Exosome Rapid Molecular Detection Product Features and Attributes
11.10.4 AMSBio Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Corporation Information
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Rapid Molecular Detection Product Features and Attributes
11.11.4 Aethlon Medical Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.11.5 Aethlon Medical Recent Developments
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Corporation Information
11.12.2 Anjarium Biosciences Business Overview
11.12.3 Anjarium Biosciences Exosome Rapid Molecular Detection Product Features and Attributes
11.12.4 Anjarium Biosciences Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.12.5 Anjarium Biosciences Recent Developments
11.13 Ciloa
11.13.1 Ciloa Corporation Information
11.13.2 Ciloa Business Overview
11.13.3 Ciloa Exosome Rapid Molecular Detection Product Features and Attributes
11.13.4 Ciloa Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.13.5 Ciloa Recent Developments
11.14 InnovaPrep
11.14.1 InnovaPrep Corporation Information
11.14.2 InnovaPrep Business Overview
11.14.3 InnovaPrep Exosome Rapid Molecular Detection Product Features and Attributes
11.14.4 InnovaPrep Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.14.5 InnovaPrep Recent Developments
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Corporation Information
11.15.2 Creative Medical Technologies Business Overview
11.15.3 Creative Medical Technologies Exosome Rapid Molecular Detection Product Features and Attributes
11.15.4 Creative Medical Technologies Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.15.5 Creative Medical Technologies Recent Developments
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Corporation Information
11.16.2 ILIAS Biologics Business Overview
11.16.3 ILIAS Biologics Exosome Rapid Molecular Detection Product Features and Attributes
11.16.4 ILIAS Biologics Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.16.5 ILIAS Biologics Recent Developments
11.17 Unchained Labs
11.17.1 Unchained Labs Corporation Information
11.17.2 Unchained Labs Business Overview
11.17.3 Unchained Labs Exosome Rapid Molecular Detection Product Features and Attributes
11.17.4 Unchained Labs Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.17.5 Unchained Labs Recent Developments
11.18 Rion
11.18.1 Rion Corporation Information
11.18.2 Rion Business Overview
11.18.3 Rion Exosome Rapid Molecular Detection Product Features and Attributes
11.18.4 Rion Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.18.5 Rion Recent Developments
11.19 Cell Guidance System
11.19.1 Cell Guidance System Corporation Information
11.19.2 Cell Guidance System Business Overview
11.19.3 Cell Guidance System Exosome Rapid Molecular Detection Product Features and Attributes
11.19.4 Cell Guidance System Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.19.5 Cell Guidance System Recent Developments
11.20 INOVIQ
11.20.1 INOVIQ Corporation Information
11.20.2 INOVIQ Business Overview
11.20.3 INOVIQ Exosome Rapid Molecular Detection Product Features and Attributes
11.20.4 INOVIQ Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.20.5 INOVIQ Recent Developments
11.21 Danaher
11.21.1 Danaher Corporation Information
11.21.2 Danaher Business Overview
11.21.3 Danaher Exosome Rapid Molecular Detection Product Features and Attributes
11.21.4 Danaher Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.21.5 Danaher Recent Developments
11.22 Exopharm
11.22.1 Exopharm Corporation Information
11.22.2 Exopharm Business Overview
11.22.3 Exopharm Exosome Rapid Molecular Detection Product Features and Attributes
11.22.4 Exopharm Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.22.5 Exopharm Recent Developments
11.23 Everzom
11.23.1 Everzom Corporation Information
11.23.2 Everzom Business Overview
11.23.3 Everzom Exosome Rapid Molecular Detection Product Features and Attributes
11.23.4 Everzom Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.23.5 Everzom Recent Developments
11.24 RoosterBio
11.24.1 RoosterBio Corporation Information
11.24.2 RoosterBio Business Overview
11.24.3 RoosterBio Exosome Rapid Molecular Detection Product Features and Attributes
11.24.4 RoosterBio Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.24.5 RoosterBio Recent Developments
11.25 Creative Biolabs
11.25.1 Creative Biolabs Corporation Information
11.25.2 Creative Biolabs Business Overview
11.25.3 Creative Biolabs Exosome Rapid Molecular Detection Product Features and Attributes
11.25.4 Creative Biolabs Exosome Rapid Molecular Detection Revenue and Gross Margin (2020-2025)
11.25.5 Creative Biolabs Recent Developments
12 Exosome Rapid Molecular DetectionIndustry Chain Analysis
12.1 Exosome Rapid Molecular Detection Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Exosome Rapid Molecular Detection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Exosome Rapid Molecular Detection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Exosome Rapid Molecular Detection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Exosome Rapid Molecular Detection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Exosome Rapid Molecular Detection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Exosome Rapid Molecular Detection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Exosome Rapid Molecular Detection Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Exosome Rapid Molecular Detection Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Exosome Rapid Molecular Detection by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Rapid Molecular Detection as of 2024)
Table 11. Global Exosome Rapid Molecular Detection Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Exosome Rapid Molecular Detection Companies Headquarters
Table 13. Global Exosome Rapid Molecular Detection Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Exosome Rapid Molecular Detection Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Exosome Rapid Molecular Detection Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Exosome Rapid Molecular Detection Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Exosome Rapid Molecular Detection Revenue by Application (2026-2031) & (US$ Million)
Table 21. Exosome Rapid Molecular Detection High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Exosome Rapid Molecular Detection Growth Accelerators and Market Barriers
Table 25. North America Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Exosome Rapid Molecular Detection Growth Accelerators and Market Barriers
Table 27. Europe Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Exosome Rapid Molecular Detection Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Exosome Rapid Molecular Detection Investment Opportunities and Key Challenges
Table 31. Central and South America Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Exosome Rapid Molecular Detection Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Exosome Rapid Molecular Detection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Corporation Information
Table 35. Thermo Fisher Scientific Description and Major Businesses
Table 36. Thermo Fisher Scientific Product Features and Attributes
Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Exosome Rapid Molecular Detection SWOT Analysis
Table 42. Thermo Fisher Scientific Recent Developments
Table 43. Bio-Techne Corporation Information
Table 44. Bio-Techne Description and Major Businesses
Table 45. Bio-Techne Product Features and Attributes
Table 46. Bio-Techne Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bio-Techne Revenue Proportion by Product in 2024
Table 48. Bio-Techne Revenue Proportion by Application in 2024
Table 49. Bio-Techne Revenue Proportion by Geographic Area in 2024
Table 50. Bio-Techne Exosome Rapid Molecular Detection SWOT Analysis
Table 51. Bio-Techne Recent Developments
Table 52. System Biosciences Corporation Information
Table 53. System Biosciences Description and Major Businesses
Table 54. System Biosciences Product Features and Attributes
Table 55. System Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. System Biosciences Revenue Proportion by Product in 2024
Table 57. System Biosciences Revenue Proportion by Application in 2024
Table 58. System Biosciences Revenue Proportion by Geographic Area in 2024
Table 59. System Biosciences Exosome Rapid Molecular Detection SWOT Analysis
Table 60. System Biosciences Recent Developments
Table 61. QIAGEN Corporation Information
Table 62. QIAGEN Description and Major Businesses
Table 63. QIAGEN Product Features and Attributes
Table 64. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. QIAGEN Revenue Proportion by Product in 2024
Table 66. QIAGEN Revenue Proportion by Application in 2024
Table 67. QIAGEN Revenue Proportion by Geographic Area in 2024
Table 68. QIAGEN Exosome Rapid Molecular Detection SWOT Analysis
Table 69. QIAGEN Recent Developments
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Major Businesses
Table 72. Lonza Product Features and Attributes
Table 73. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Lonza Revenue Proportion by Product in 2024
Table 75. Lonza Revenue Proportion by Application in 2024
Table 76. Lonza Revenue Proportion by Geographic Area in 2024
Table 77. Lonza Exosome Rapid Molecular Detection SWOT Analysis
Table 78. Lonza Recent Developments
Table 79. NX Pharmagen Corporation Information
Table 80. NX Pharmagen Description and Major Businesses
Table 81. NX Pharmagen Product Features and Attributes
Table 82. NX Pharmagen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. NX Pharmagen Recent Developments
Table 84. NanoSomiX Corporation Information
Table 85. NanoSomiX Description and Major Businesses
Table 86. NanoSomiX Product Features and Attributes
Table 87. NanoSomiX Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. NanoSomiX Recent Developments
Table 89. Miltenyi Biotech Corporation Information
Table 90. Miltenyi Biotech Description and Major Businesses
Table 91. Miltenyi Biotech Product Features and Attributes
Table 92. Miltenyi Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Miltenyi Biotech Recent Developments
Table 94. Norgen Biotek Corporation Information
Table 95. Norgen Biotek Description and Major Businesses
Table 96. Norgen Biotek Product Features and Attributes
Table 97. Norgen Biotek Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Norgen Biotek Recent Developments
Table 99. AMSBio Corporation Information
Table 100. AMSBio Description and Major Businesses
Table 101. AMSBio Product Features and Attributes
Table 102. AMSBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. AMSBio Recent Developments
Table 104. Aethlon Medical Corporation Information
Table 105. Aethlon Medical Description and Major Businesses
Table 106. Aethlon Medical Product Features and Attributes
Table 107. Aethlon Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Aethlon Medical Recent Developments
Table 109. Anjarium Biosciences Corporation Information
Table 110. Anjarium Biosciences Description and Major Businesses
Table 111. Anjarium Biosciences Product Features and Attributes
Table 112. Anjarium Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Anjarium Biosciences Recent Developments
Table 114. Ciloa Corporation Information
Table 115. Ciloa Description and Major Businesses
Table 116. Ciloa Product Features and Attributes
Table 117. Ciloa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Ciloa Recent Developments
Table 119. InnovaPrep Corporation Information
Table 120. InnovaPrep Description and Major Businesses
Table 121. InnovaPrep Product Features and Attributes
Table 122. InnovaPrep Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. InnovaPrep Recent Developments
Table 124. Creative Medical Technologies Corporation Information
Table 125. Creative Medical Technologies Description and Major Businesses
Table 126. Creative Medical Technologies Product Features and Attributes
Table 127. Creative Medical Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Creative Medical Technologies Recent Developments
Table 129. ILIAS Biologics Corporation Information
Table 130. ILIAS Biologics Description and Major Businesses
Table 131. ILIAS Biologics Product Features and Attributes
Table 132. ILIAS Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. ILIAS Biologics Recent Developments
Table 134. Unchained Labs Corporation Information
Table 135. Unchained Labs Description and Major Businesses
Table 136. Unchained Labs Product Features and Attributes
Table 137. Unchained Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Unchained Labs Recent Developments
Table 139. Rion Corporation Information
Table 140. Rion Description and Major Businesses
Table 141. Rion Product Features and Attributes
Table 142. Rion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Rion Recent Developments
Table 144. Cell Guidance System Corporation Information
Table 145. Cell Guidance System Description and Major Businesses
Table 146. Cell Guidance System Product Features and Attributes
Table 147. Cell Guidance System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Cell Guidance System Recent Developments
Table 149. INOVIQ Corporation Information
Table 150. INOVIQ Description and Major Businesses
Table 151. INOVIQ Product Features and Attributes
Table 152. INOVIQ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. INOVIQ Recent Developments
Table 154. Danaher Corporation Information
Table 155. Danaher Description and Major Businesses
Table 156. Danaher Product Features and Attributes
Table 157. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Danaher Recent Developments
Table 159. Exopharm Corporation Information
Table 160. Exopharm Description and Major Businesses
Table 161. Exopharm Product Features and Attributes
Table 162. Exopharm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Exopharm Recent Developments
Table 164. Everzom Corporation Information
Table 165. Everzom Description and Major Businesses
Table 166. Everzom Product Features and Attributes
Table 167. Everzom Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. Everzom Recent Developments
Table 169. RoosterBio Corporation Information
Table 170. RoosterBio Description and Major Businesses
Table 171. RoosterBio Product Features and Attributes
Table 172. RoosterBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. RoosterBio Recent Developments
Table 174. Creative Biolabs Corporation Information
Table 175. Creative Biolabs Description and Major Businesses
Table 176. Creative Biolabs Product Features and Attributes
Table 177. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Creative Biolabs Recent Developments
Table 179. Raw Materials Key Suppliers
Table 180. Distributors List
Table 181. Market Trends and Market Evolution
Table 182. Market Drivers and Opportunities
Table 183. Market Challenges, Risks, and Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources


List of Figures
Figure 1. Exosome Rapid Molecular Detection Product Picture
Figure 2. Global Exosome Rapid Molecular Detection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Kits & Reagents Product Picture
Figure 4. Instruments Product Picture
Figure 5. Services Product Picture
Figure 6. Global Exosome Rapid Molecular Detection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Cancers
Figure 8. Neurodegenerative Diseases
Figure 9. Cardiovascular Diseases
Figure 10. Infectious Diseases
Figure 11. Other
Figure 12. Exosome Rapid Molecular Detection Report Years Considered
Figure 13. Global Exosome Rapid Molecular Detection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 15. Global Exosome Rapid Molecular Detection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Exosome Rapid Molecular Detection Revenue Market Share by Region (2020-2031)
Figure 17. Global Exosome Rapid Molecular Detection Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Kits & Reagents Revenue Market Share by Player in 2024
Figure 20. Instruments Revenue Market Share by Player in 2024
Figure 21. Services Revenue Market Share by Player in 2024
Figure 22. Global Exosome Rapid Molecular Detection Revenue Market Share by Type (2020-2031)
Figure 23. Global Exosome Rapid Molecular Detection Revenue Market Share by Application (2020-2031)
Figure 24. North America Exosome Rapid Molecular Detection Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Exosome Rapid Molecular Detection Revenue (US$ Million) in 2024
Figure 26. North America Exosome Rapid Molecular Detection Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Exosome Rapid Molecular Detection Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Exosome Rapid Molecular Detection Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Exosome Rapid Molecular Detection Revenue (US$ Million) in 2024
Figure 33. Europe Exosome Rapid Molecular Detection Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Exosome Rapid Molecular Detection Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 36. France Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Exosome Rapid Molecular Detection Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Exosome Rapid Molecular Detection Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Exosome Rapid Molecular Detection Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Exosome Rapid Molecular Detection Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 48. India Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Exosome Rapid Molecular Detection Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Exosome Rapid Molecular Detection Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Exosome Rapid Molecular Detection Revenue (US$ Million) in 2024
Figure 56. Central and South America Exosome Rapid Molecular Detection Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Exosome Rapid Molecular Detection Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Exosome Rapid Molecular Detection Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Exosome Rapid Molecular Detection Revenue (US$ Million) in 2024
Figure 62. South America Exosome Rapid Molecular Detection Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Exosome Rapid Molecular Detection Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Exosome Rapid Molecular Detection Revenue (2020-2025) & (US$ Million)
Figure 68. Exosome Rapid Molecular Detection Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit